HLX14

BIOLOGICAL2 trials

Sponsors

Shanghai Henlius Biotech

Conditions

Healthy Male VolunteersPostmenopausal

Phase 1

Pharmacokinetic, Safety and Immunogenicity Phase I Study of HLX14 Versus Prolia® in Healthy Male Subjects

CompletedNCT04534582

Shanghai Henlius BiotechHealthy Male Volunteers

Start: 2020-11-03End: 2023-09-12Updated: 2025-01-20

Phase 3

A Study to Evaluate the Efficacy and Safety of HLX14 vs. Denosumab Prolia® in Postmenopausal Women With Osteoporosis at High Risk of Fracture

CompletedNCT05352516

Shanghai Henlius BiotechPostmenopausal

Start: 2022-06-17End: 2024-07-03Updated: 2024-09-20